You are here: Home » Current Affairs » Coronavirus » News
Business Standard

'Karnataka facility can produce 40-50 mn Covaxin doses a month by Aug-end'

Bharat Biotech's Covaxin manufacturing facility that is under construction in Karnataka would have a manufacturing capacity of 40 to 50 million doses a month by August-end, says state Health Minister

Bharat Biotech | Coronavirus Vaccine | Karnataka

Press Trust of India  |  Bengaluru 


Bharat Biotech's Covaxin

manufacturing facility that is under construction in Kolar district in would have a manufacturing capacity of four to five crore doses a month by August-end, state Health Minister Dr K Sudhakar said on Monday.

Talking to reporters here ahead of his meeting with the experts on mucormycosis, known as as black fungus, which is emerging as a new threat to those who recover from COVID- 19, Sudhakar said he had a video conference with founder Dr Krishna Ella, his daughter Dr Jala Ella and rest of the team.

"Dr Ella has assured me that their facility at Malur in Kolar will be able to produce one crore vaccines by June- end. By July-end it will be by two to three crores, and their target by August-end is four crore to five crore vaccine doses," Sudhakar said.

According to him, Krishna Ella and all the directors assured him that they will give vaccines to at the earliest.

The minister said he asked them to provide a roll-out schedule as well, which they will do soon.

officials will be in touch with them on how to roll out the vaccine in the state in the coming days.

"Our priority is to get the vaccines to the people of our state at the earliest," Sudhakar said.

He also said that Bharat Biotech's facility in Hyderabad can produce one crore doses of COVID vaccine a month whereas the Karnataka unit will roll out four to five crore doses a month from August onwards.

To a question, Sudhakar said Chief Minister B S Yediyurappa would be holding a meeting in the evening where a detailed discussion will take place on the extension of lockdown following which a decision will be taken.

Replying to a query on the Congress questioning the Narendra Modi government at the Centre for allegedly selling the vaccines, Sudhakar said it was donated by the Centre to the COVID affected nations on humanitarian grounds as no one foresaw the severity of the second wave.

He said it was highly regrettable that the Congress was indulging in politics despite assuring the government that it will cooperate with it in the fight against COVID.

Karnataka has so far conducted 1.12 crore inoculations of coronavirus vaccines in the state comprising first and second doses whereas it has suspended the vaccination of people between the age group of 18 and 44, who are about 3.5 crore, due to shortage of vaccines.

The state is battered by the second wave of COVID infections and reported 31,531 infections and 403 deaths on Sunday.

There are over six lakh active cases in the state, a majority of whom are in Bengaluru.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Mon, May 17 2021. 16:07 IST